Don't want to miss the best from Business Standard?
Monday, December 01, 2025 | 04:12 AM ISTहिंदी में पढें
Torrent Pharma in advanced talks to acquire JB Chemicals from KKR
Torrent Pharma is negotiating to acquire JB Chemicals from KKR in a deal that may trigger an open offer, strengthening its position in the domestic pharma market
 "Torrent Pharma")
premium
In the financial year ended March 2025, Torrent Pharma reported revenue of ₹11,516 crore and a net profit of ₹1,911 crore. | Photo: Shutterstock
Torrent Pharmaceuticals is in advanced negotiations to acquire JB Chemicals & Pharmaceuticals from America-based private-equity firm KKR & Co, according to people familiar with the matter.
The Ahmedabad-based drugmaker is looking to consolidate its presence in the domestic pharmaceutical market.
KKR & Co owns 47.84 per cent in JB Chemicals and any transaction will trigger a mandatory open offer for public shareholders under takeover regulations.
The private-equity firm’s stake was valued at ₹13,461 crore ($1.57 billion) as of Friday’s close, with JB Chemicals’ shares ending at ₹1,800 apiece, giving the company a market capitalisation of ₹28,080 crore ($3.27 billion).
The
